Tissue Therapies Limited is an Australia-based biomedical technology company which develops and manufactures proteins for healing wounds. The Company provides effective treatments for acute and chronic wound, including chronic skin ulcers and burns. The company also provides treatments for psoriasis, scar prevention and various cancers including those of the breast, colon and prostate. VitroGro ECM, a product of Tissue Therapies, is a solution of synthetic protein that promotes healing and reduces pain in chronic wounds. The product is applied to the surface of a prepared wound and the liquid formulation allows the product to cover the irregular shape of the wound. Tissue Therapies Europe Limited a wholly owned subsidiary which is set up to provide administration support to Tissue Therapies Limited.